Challenges of T cell therapies for virus-associated diseases after hematopoietic stem cell transplantation

Importance of the field: Hematopoietic stem cell transplantation (HSCT) is the treatment of choice for many hematological malignancies and genetic disorders. The majority of patients do not have a human leukocyte antigen (HLA) identical sibling donor, and alternative stem cell sources include HLA-matched or mismatched unrelated donors and haploidentical related donors. However, alternative donor HSCT are associated with three major complications i) graft rejection; ii) graft-versus-host disease (GvHD); and iii) delayed immune reconstitution leading to viral infections and relapse. Areas covered in this review: Graft rejection and the risk of GvHD can be significantly reduced by using intensive conditioning regimens, including in vivo T cell depletion as well as ex vivo T cell depletion of the graft. However, the benefits of removing alloreactive T cells from the graft are offset by the concomitant removal of T cells with anti-viral or anti-tumor activity as well as the profound delay in endogenous T cell recovery post-transplant. Thus, opportunistic infections, many of which are not amenable to conventional small-molecule therapeutics, are frequent in these patients and are associated with significant morbidity and high mortality rates. This review discusses current cell therapies to prevent or treat viral infections/reactivations post-transplant. What the reader will gain: The reader will gain an understanding of the current state of cell therapy to prevent and treat viral infections post-HSCT, and will be introduced to preclinical studies designed to develop and validate new manufacturing procedures intended to improve therapeutic efficacy and reduce associated toxicities. Take home message: Reconstitution of HSCT recipients with antigen-specific T cells, produced either by allodepletion or in vitro reactivation, can offer an effective strategy to provide both immediate and long-term protection without harmful alloreactivity.

[1]  C. Huber,et al.  Depletion of alloreactive T cells via CD69: implications on antiviral, antileukemic and immunoregulatory T lymphocytes , 2006, Bone Marrow Transplantation.

[2]  R. Andreesen,et al.  Large scale in vitro expansion of polyclonal human CD4+CD25high regulatory T cells , 2004, Cancer Cell International.

[3]  U. Gerdemann,et al.  Nucleofection of DCs to generate Multivirus-specific T cells for prevention or treatment of viral infections in the immunocompromised host. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[4]  F. Rovida,et al.  Impact of human metapneumovirus and human cytomegalovirus versus other respiratory viruses on the lower respiratory tract infections of lung transplant recipients , 2006, Journal of medical virology.

[5]  K. St. George,et al.  Diagnosis of Human Metapneumovirus Infection in Immunosuppressed Lung Transplant Recipients and Children Evaluated for Pertussis , 2006, Journal of Clinical Microbiology.

[6]  Robert H. Collins,et al.  Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  J. Gribben,et al.  Transplantation of anergic histoincompatible bone marrow allografts. , 1999, The New England journal of medicine.

[8]  M. Debakey,et al.  West Nile Virus Encephalopathy Following Pancreatic Islet Transplantation , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[9]  P. Szabolcs,et al.  Successful treatment of human herpesvirus 6 encephalitis in a bone marrow transplant recipient. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  Brief report: Lymphocytic choriomeningitis virus transmitted through solid organ transplantation--Massachusetts, 2008. , 2008, MMWR. Morbidity and mortality weekly report.

[11]  J. Morales,et al.  Correlation between fibroscan, liver biopsy, and clinical liver function in patients with hepatitis C virus infection after renal transplantation. , 2009, Transplantation proceedings.

[12]  Zhensheng Liu,et al.  CD20 monoclonal antibody (rituximab) for therapy of Epstein-Barr virus lymphoma after hemopoietic stem-cell transplantation. , 2000, Blood.

[13]  D. Porter,et al.  Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia. , 1994, The New England journal of medicine.

[14]  A. Zander,et al.  Efficient depletion of alloreactive donor T lymphocytes based on expression of two activation‐induced antigens (CD25 and CD69) , 2000, British journal of haematology.

[15]  J. Simons,et al.  A new arenavirus in a cluster of fatal transplant-associated diseases. , 2008, The New England journal of medicine.

[16]  Lymphocytic choriomeningitis virus infection in organ transplant recipients--Massachusetts, Rhode Island, 2005. , 2005, MMWR. Morbidity and mortality weekly report.

[17]  P. Ljungman,et al.  BK-viruria and haemorrhagic cystitis are more frequent in allogeneic haematopoietic stem cell transplant patients receiving full conditioning and unrelated-HLA-mismatched grafts , 2008, Bone Marrow Transplantation.

[18]  R. Couch,et al.  Community respiratory virus infections among hospitalized adult bone marrow transplant recipients. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  S. Mackinnon,et al.  Induction of cytomegalovirus (CMV)-specific T-cell responses using dendritic cells pulsed with CMV antigen: a novel culture system free of live CMV virions. , 2001, Blood.

[20]  Deepali Kumar,et al.  Severe Acute Respiratory Syndrome (SARS) in a Liver Transplant Recipient and Guidelines for Donor SARS Screening , 2003, American Journal of Transplantation.

[21]  H. Heslop,et al.  Adenovirus infection after pediatric bone marrow transplantation , 1999, Bone Marrow Transplantation.

[22]  L. Krogerus,et al.  Pretransplant Human Herpesvirus 6 Infection of Patients with Acute Liver Failure Is a Risk Factor for Posttransplant Human Herpesvirus 6 Infection of the Liver , 2006, Transplantation.

[23]  C. Craddock,et al.  Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation. , 2001, Blood.

[24]  T. Pumarola,et al.  Infection with Human Herpesvirus 6 after Kidney‐Pancreas Transplant , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[25]  A Ferrant,et al.  Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. , 1995, Blood.

[26]  R. Gohh,et al.  Donor‐transmitted parvovirus infection in a kidney transplant recipient presenting as pancytopenia and allograft dysfunction , 2002, Transplant infectious disease : an official journal of the Transplantation Society.

[27]  J. Kopp,et al.  Parvovirus-B19-associated complications in renal transplant recipients , 2007, Nature Clinical Practice Nephrology.

[28]  A. Fischer,et al.  Immune reconstitution without graft-versus-host disease after haemopoietic stem-cell transplantation: a phase 1/2 study , 2002, The Lancet.

[29]  B. Barlogie,et al.  Thymidine kinase (TK) gene-transduced human lymphocytes can be highly purified, remain fully functional, and are killed efficiently with ganciclovir. , 1997, Blood.

[30]  T. Rochat,et al.  A Prospective Hospital-Based Study of the Clinical Impact of Non–Severe Acute Respiratory Syndrome (Non-SARS)–Related Human Coronavirus Infection , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[31]  F. Baldanti,et al.  Preemptive Therapy of EBV‐Related Lymphoproliferative Disease after Pediatric Haploidentical Stem Cell Transplantation , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[32]  M Pittard,et al.  Adenovirus infections in hematopoietic stem cell transplant recipients. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[33]  D. Andrews,et al.  Late graft failure due to dual bone marrow infection with variants A and B of human herpesvirus-6. , 1995, Experimental hematology.

[34]  S. Rosenberg,et al.  Culture of human tumor infiltrating lymphocytes in hollow fiber bioreactors. , 1990, Journal of immunological methods.

[35]  J. Connors,et al.  Long-term follow-up of patients who achieved complete remission after donor leukocyte infusions. , 1999, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[36]  A. Swerdlow,et al.  Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial. , 2007, Blood.

[37]  F. Ginevri,et al.  Cellular immune responses to BK virus , 2008, Current opinion in organ transplantation.

[38]  Helen E Heslop,et al.  Accelerated Production of Antigen-specific T Cells for Preclinical and Clinical Applications Using Gas-permeable Rapid Expansion Cultureware (G-Rex) , 2010, Journal of immunotherapy.

[39]  R. Pierce,et al.  Detection of Severe Human Metapneumovirus Infection by Real-Time Polymerase Chain Reaction and Histopathological Assessment , 2005, The Journal of infectious diseases.

[40]  C. Rinaldo,et al.  Successful Outcome of Human Metapneumovirus (hMPV) Pneumonia in a Lung Transplant Recipient Treated With Intravenous Ribavirin , 2007, The Journal of Heart and Lung Transplantation.

[41]  Shamsul A. Khan,et al.  Depletion of alloreactive donor T lymphocytes by CD95-mediated activation-induced cell death retains antileukemic, antiviral, and immunoregulatory T cell immunity. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[42]  L. Elting,et al.  Adenovirus infections in adult recipients of blood and marrow transplants. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[43]  R. Fukunaga,et al.  Human herpesvirus 6 ganciclovir-resistant strain with amino acid substitutions associated with the death of an allogeneic stem cell transplant recipient. , 2009, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[44]  U. Kontny,et al.  Disseminated Bocavirus Infection after Stem Cell Transplant , 2007, Emerging infectious diseases.

[45]  S. Allegrini,et al.  Detection, distribution, and pathologic significance of BK virus strains isolated from patients with kidney transplants, with and without polyomavirus-associated nephropathy. , 2009, Archives of pathology & laboratory medicine.

[46]  Chung-Che Chang,et al.  Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals , 2006, Nature Medicine.

[47]  Hans H Hirsch,et al.  Viral dynamics in transplant patients: implications for disease. , 2007, The Lancet. Infectious diseases.

[48]  A. Tosti,et al.  Photodynamic purging of alloreactive T cells for adoptive immunotherapy after haploidentical stem cell transplantation. , 2008, Blood cells, molecules & diseases.

[49]  Shamsul A. Khan,et al.  Targeting the activation-induced antigen CD137 can selectively deplete alloreactive T cells from antileukemic and antitumor donor T-cell lines. , 2007, Blood.

[50]  H. Heslop,et al.  Cytotoxic T lymphocytes as immune‐therapy in haematological practice , 2008, British journal of haematology.

[51]  S. Mackinnon,et al.  Comparison of Immune Reconstitution After Unrelated and Related T-Cell – Depleted Bone Marrow Transplantation : Effect of Patient Age and Donor Leukocyte Infusions , 1998 .

[52]  K. Kain,et al.  Fatal Severe Acute Respiratory Syndrome Is Associated with Multiorgan Involvement by Coronavirus , 2005, The Journal of infectious diseases.

[53]  K. Rezvani,et al.  High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT. , 2006, Blood.

[54]  Malcolm K. Brenner,et al.  Identification of Hexon-Specific CD4 and CD8 T-Cell Epitopes for Vaccine and Immunotherapy , 2007, Journal of Virology.

[55]  Deepali Kumar,et al.  Community-acquired West Nile virus infection in solid-organ transplant recipients , 2004, Transplantation.

[56]  J. Bell,et al.  Functional Heterogeneity and High Frequencies of Cytomegalovirus-Specific CD8+ T Lymphocytes in Healthy Seropositive Donors , 2000, Journal of Virology.

[57]  R. Montgomery,et al.  West Nile Virus Encephalitis in a Kidney Transplant Recipient , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[58]  A. Bertoletti,et al.  Heterologous T cell immunity in severe hepatitis C virus infection , 2005, The Journal of experimental medicine.

[59]  E. Whimbey,et al.  Respiratory syncytial virus infections in immunocompromised adults. , 2000, Current clinical topics in infectious diseases.

[60]  K. Cornetta,et al.  Donor leukocyte infusion as therapy of life-threatening adenoviral infections after T-cell-depleted bone marrow transplantation. , 1994, Blood.

[61]  J. Morales,et al.  Clinical Implications of Respiratory Virus Infections in Solid Organ Transplant Recipients: A Prospective Study , 2007, Transplantation.

[62]  M. Lowdell,et al.  Antiviral immunity and T-regulatory cell function are retained after selective alloreactive T-cell depletion in both the HLA-identical and HLA-mismatched settings. , 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[63]  S. Fischer.  Emerging Viruses in Transplantation: There Is More to Infection After Transplant Than CMV and EBV , 2008, Transplantation.

[64]  D. Kavanagh,et al.  Acute respiratory infection in a renal transplant recipient. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[65]  M-J Zhang,et al.  Correlations of human herpesvirus 6B and CMV infection with acute GVHD in recipients of allogeneic haematopoietic stem cell transplantation , 2008, Bone Marrow Transplantation.

[66]  B. Griffith,et al.  The epidemiology of parainfluenza virus infection in lung transplant recipients. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[67]  Z. Azzam,et al.  West Nile meningo-encephalitis infection in a kidney transplant recipient. , 2003, Transplantation proceedings.

[68]  A. Davis,et al.  Large-Scale Expansion of Dendritic Cell-Primed Polyclonal Human Cytotoxic T-Lymphocyte Lines Using Lymphoblastoid Cell Lines for Adoptive Immunotherapy , 2003, Journal of immunotherapy.

[69]  R. Dillman,et al.  Characterization of human tumor-infiltrating lymphocytes expanded in hollow-fiber bioreactors for immunotherapy of cancer. , 2001, Cancer biotherapy & radiopharmaceuticals.

[70]  G. Behre,et al.  Human parvovirus B19 infection with GvHD-like erythema in two allogeneic stem cell transplant recipients , 2007, Bone Marrow Transplantation.

[71]  Malcolm K. Brenner,et al.  Long–term restoration of immunity against Epstein–Barr virus infection by adoptive transfer of gene–modified virus–specific T lymphocytes , 1996, Nature Medicine.

[72]  J. Michálek,et al.  Optimized clinical-scale culture conditions for ex vivo selective depletion of host-reactive donor lymphocytes: a strategy for GvHD prophylaxis in allogeneic PBSC transplantation. , 2002, Cytotherapy.

[73]  H. Volk,et al.  Analysis of CD8 T cell reactivity to cytomegalovirus using protein‐spanning pools of overlapping pentadecapeptides , 2000, European journal of immunology.

[74]  E. Kieff,et al.  Recognition of the Epstein-Barr virus-encoded nuclear antigens EBNA-4 and EBNA-6 by HLA-A11-restricted cytotoxic T lymphocytes: implications for down-regulation of HLA-A11 in Burkitt lymphoma. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[75]  U. Querfeld,et al.  Severe parvovirus B19 encephalitis after renal transplantation , 2006, Pediatric transplantation.

[76]  R. Krance,et al.  Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation , 1995, The Lancet.

[77]  R. Noelle,et al.  CD4(+) T cells tolerized ex vivo to host alloantigen by anti-CD40 ligand (CD40L:CD154) antibody lose their graft-versus-host disease lethality capacity but retain nominal antigen responses. , 1998, The Journal of clinical investigation.

[78]  A. Cariou,et al.  Coronavirus 229E-Related Pneumonia in Immunocompromised Patients , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[79]  N. Chao,et al.  Prevention of graft-versus-host disease while preserving graft-versus-leukemia effect after selective depletion of host-reactive T cells by photodynamic cell purging process. , 2002, Blood.

[80]  Shamsul A. Khan,et al.  Selective Depletion of Alloreactive T Lymphocytes Using Patient-Derived Nonhematopoietic Stimulator Cells in Allograft Engineering , 2008, Transplantation.

[81]  A. Cometa,et al.  Human alloantigen-specific anergic cells induced by a combination of CTLA4-Ig and CsA maintain anti-leukemia and anti-viral cytotoxic responses , 2001, Bone Marrow Transplantation.

[82]  Mike Gough,et al.  Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates. , 2008, The Journal of clinical investigation.

[83]  R. Gingrich,et al.  A fatal case of West Nile virus infection in a bone marrow transplant recipient. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[84]  C. Bordignon,et al.  HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. , 1997, Science.

[85]  J. Kurtzberg,et al.  In vitro priming and expansion of cytomegalovirus-specific Th1 and Tc1 T cells from naive cord blood lymphocytes. , 2006, Blood.

[86]  J. Goldman,et al.  Molecular Epidemiology of Two Consecutive Outbreaks of Parainfluenza 3 in a Bone Marrow Transplant Unit , 1998, Journal of Clinical Microbiology.

[87]  M. Boeckh,et al.  Adenovirus infection in hematopoietic stem cell transplantation: effect of ganciclovir and impact on survival. , 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[88]  F. Ruscetti,et al.  Induction of CD4+ T cell alloantigen-specific hyporesponsiveness by IL-10 and TGF-beta. , 1999, Journal of immunology.

[89]  Nitin J. Karandikar,et al.  In vitro methotrexate as a practical approach to selective allodepletion. , 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[90]  M. Gandhi,et al.  Immunity, Homing and Efficacy of Allogeneic Adoptive Immunotherapy for Posttransplant Lymphoproliferative Disorders , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[91]  M. Clementi,et al.  Persistent symptomless human metapneumovirus infection in hematopoietic stem cell transplant recipients. , 2006, The Journal of infectious diseases.

[92]  L. Verdonck,et al.  Severe multiorgan failure after parvovirus B19 infection in an allogeneic stem cell transplant recipient , 2004, Bone Marrow Transplantation.

[93]  Nina Singh,et al.  Human herpesvirus-6 infection in liver transplant recipients: documentation of pathogenicity. , 1997, Transplantation.

[94]  C. Rooney,et al.  Adenovirus as an emerging pathogen in immunocompromised patients , 2005, British journal of haematology.

[95]  H. Heslop,et al.  Add-back of allodepleted donor T cells to improve immune reconstitution after haplo-identical stem cell transplantation. , 2005, Cytotherapy.

[96]  K. Kashima,et al.  Human herpesvirus 6 DNA in plasma after allogeneic stem cell transplantation: incidence and clinical significance. , 2006, The Journal of infectious diseases.

[97]  J. Myśliwska,et al.  First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127- T regulatory cells. , 2009, Clinical immunology.

[98]  S. Mackinnon,et al.  Adoptive cellular therapy for cytomegalovirus infection following allogeneic stem cell transplantation using virus-specific T cells. , 2008, Blood cells, molecules & diseases.

[99]  Hao Liu,et al.  Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients. , 2010, Blood.

[100]  K. Jin,et al.  Case of adult mumps infection after renal transplantation. , 2008, Transplantation proceedings.

[101]  N. Zhong,et al.  Detection of Severe Acute Respiratory Syndrome Coronavirus in the Brain: Potential Role of the Chemokine Mig in Pathogenesis , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[102]  A. Barrett,et al.  Outbreak of human parainfluenza virus 3 infections in a hematopoietic stem cell transplant population. , 2001, The Journal of infectious diseases.

[103]  M. Ladanyi,et al.  Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. , 1994, The New England journal of medicine.

[104]  E. Woodle,et al.  West Nile virus encephalitis in organ transplant recipients: another high-risk group for meningoencephalitis and death. , 2004, Transplantation.

[105]  Philippa Marrack,et al.  T cells down-modulate peptide-MHC complexes on APCs in vivo , 2002, Nature Immunology.

[106]  R. Khanna,et al.  Cross-recognition of human alloantigen by cytomegalovirus glycoprotein-specific CD4+ cytotoxic T lymphocytes: implications for graft-versus-host disease. , 2005, Blood.

[107]  Michel Sadelain,et al.  Manufacturing Validation of Biologically Functional T Cells Targeted to CD19 Antigen for Autologous Adoptive Cell Therapy , 2009, Journal of immunotherapy.

[108]  K. Tyler,et al.  Naturally acquired West Nile virus encephalomyelitis in transplant recipients: clinical, laboratory, diagnostic, and neuropathological features. , 2004, Archives of neurology.

[109]  D. Baarle,et al.  Human herpesvirus type 6 reactivation after haematopoietic stem cell transplantation. , 2008, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[110]  Arjun Srinivasan,et al.  Transmission of lymphocytic choriomeningitis virus by organ transplantation. , 2006, The New England journal of medicine.

[111]  D. Nachbaur,et al.  Human metapneumovirus infection in lung transplant recipients: clinical presentation and epidemiology. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[112]  A. Tomaszewska,et al.  Prevalence of human herpesvirus 6 antibodies and DNA in allogeneic stem cell transplant patients: two-year single centre experience , 2008, Archivum Immunologiae et Therapiae Experimentalis.

[113]  J. Michálek,et al.  Selective depletion of donor alloreactive T cells without loss of antiviral or antileukemic responses. , 2003, Blood.

[114]  C. Bordignon,et al.  Antitumor effects of HSV-TK-engineered donor lymphocytes after allogeneic stem-cell transplantation. , 2007, Blood.

[115]  M. Boeckh,et al.  Emerging viral infections after hematopoietic cell transplantation , 2005, Pediatric transplantation.

[116]  F. Ginevri,et al.  Polyomavirus‐associated nephropathy: update on BK virus‐specific immunity , 2006, Transplant infectious disease : an official journal of the Transplantation Society.

[117]  D. Henry,et al.  Clinical and laboratory features of measles in hospitalized adults. , 1993, The American journal of medicine.

[118]  J. Goldman,et al.  Parainfluenza virus 3 infection after stem cell transplant: relevance to outcome of rapid diagnosis and ribavirin treatment. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[119]  I. Folkmane,et al.  Reactivation of BK Virus in the Early Period After Kidney Transplantation. , 2009, Transplantation proceedings.

[120]  P. Hopkins,et al.  Human metapneumovirus in lung transplant recipients and comparison to respiratory syncytial virus. , 2008, American journal of respiratory and critical care medicine.

[121]  G. Fuller,et al.  West Nile encephalitis in 2 hematopoietic stem cell transplant recipients: case series and literature review. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[122]  G. Papanicolaou,et al.  Cytomegalovirus in hematopoietic stem cell transplant recipients: Current status, known challenges, and future strategies. , 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[123]  K. Rezvani,et al.  A clinical-scale selective allodepletion approach for the treatment of HLA-mismatched and matched donor-recipient pairs using expanded T lymphocytes as antigen-presenting cells and a TH9402-based photodepletion technique. , 2008, Blood.

[124]  R. Vainionpää,et al.  Parainfluenza virus type 3 infections in a hematology unit , 2001, Bone Marrow Transplantation.

[125]  H. Einsele,et al.  Isolation and expansion of human adenovirus-specific CD4+ and CD8+ T cells according to IFN-gamma secretion for adjuvant immunotherapy. , 2004, Experimental hematology.

[126]  H. Heslop,et al.  Inducible caspase 9 suicide gene to improve the safety of allodepleted T cells after haploidentical stem cell transplantation. , 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[127]  M. Bonneville,et al.  EBV-Specific CD4+ T Cell Clones Exhibit Vigorous Allogeneic Responses1 , 2006, The Journal of Immunology.

[128]  K. Iyer,et al.  Rotavirus Infection in Small Bowel Transplant: A Histologic Comparison with Acute Cellular Rejection , 2009, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[129]  E. Holler,et al.  Adenoviral infection after allogeneic stem cell transplantation (SCT): report on 130 patients from a single SCT unit involved in a prospective multi center surveillance study , 2001, Bone Marrow Transplantation.

[130]  J. Sejvar,et al.  Persistent neuroinvasive West Nile virus infection in an immunocompromised patient. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[131]  M. Boeckh,et al.  Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome. , 2001, Blood.

[132]  Philippa Marrack,et al.  T Cells Compete for Access to Antigen-Bearing Antigen-Presenting Cells , 2000, The Journal of experimental medicine.

[133]  A. Swerdlow,et al.  Treatment of Epstein-Barr-virus-positive post-transplantation lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cells , 2002, The Lancet.

[134]  H. Heslop,et al.  An inducible caspase 9 safety switch for T-cell therapy. , 2005, Blood.

[135]  I. Pastan,et al.  Specific depletion of alloreactivity against haplotype mismatched related individuals by a recombinant immunotoxin: a new approach to graft-versus-host disease prophylaxis in haploidentical bone marrow transplantation. , 1996, Bone marrow transplantation.

[136]  M. Boeckh,et al.  Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[137]  H. Heslop,et al.  Donor T cells to treat EBV-associated lymphoma. , 1994, The New England journal of medicine.

[138]  A. Barrett,et al.  Selective depletion of alloreactive donor lymphocytes: a novel method to reduce the severity of graft-versus-host disease in older patients undergoing matched sibling donor stem cell transplantation. , 2005, Blood.

[139]  R. Krance,et al.  Adenovirus infection rates in pediatric recipients of alternate donor allogeneic bone marrow transplants receiving either antithymocyte globulin (ATG) or alemtuzumab (Campath) , 2005, Bone Marrow Transplantation.

[140]  P. Hanley,et al.  Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopes. , 2009, Blood.

[141]  E. Holler,et al.  Long-term parvovirus B19 viraemia associated with pure red cell aplasia after allogeneic bone marrow transplantation. , 2004, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[142]  A. Rickinson,et al.  Cellular responses to viral infection in humans: lessons from Epstein-Barr virus. , 2007, Annual review of immunology.

[143]  J. Gribben,et al.  Outcome of alloanergized haploidentical bone marrow transplantation after ex vivo costimulatory blockade: results of 2 phase 1 studies. , 2008, Blood.

[144]  C. Craddock,et al.  Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA–peptide tetramers , 2005, The Journal of experimental medicine.

[145]  S. Singhal,et al.  Identification of patients who may benefit from prophylactic immunotherapy after bone marrow transplantation for acute myeloid leukemia on the basis of lymphocyte recovery early after transplantation. , 1998, Blood.

[146]  G. Botti,et al.  Prospective Monitoring of Polyomavirus BK Replication and Impact of Pre‐Emptive Intervention in Pediatric Kidney Recipients , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[147]  S. Mackinnon,et al.  Adoptive immunotherapy using donor leukocytes following bone marrow transplantation for chronic myeloid leukemia: is T cell dose important in determining biological response? , 1995, Bone marrow transplantation.

[148]  C. Perreault,et al.  P-glycoprotein targeting: a unique strategy to selectively eliminate immunoreactive T cells. , 2002, Blood.

[149]  L. Verdonck,et al.  Selective depletion of major and minor histocompatibility antigen reactive T cells: towards prevention of acute graft‐versus‐host disease , 1999, British journal of haematology.

[150]  S. Forman,et al.  Manufacturing of Large Numbers of Patient-specific T Cells for Adoptive Immunotherapy: An Approach to Improving Product Safety, Composition, and Production Capacity , 2007, Journal of immunotherapy.

[151]  H. Heslop,et al.  Exploiting Cytokine Secretion to Rapidly Produce Multivirus-specific T Cells for Adoptive Immunotherapy , 2008, Journal of immunotherapy.

[152]  P. Gallian,et al.  Human Parvovirus 4 in Kidney Transplant Patients, France , 2008, Emerging infectious diseases.

[153]  M. Masucci,et al.  Multiple HLA A11-restricted cytotoxic T-lymphocyte epitopes of different immunogenicities in the Epstein-Barr virus-encoded nuclear antigen 4 , 1993, Journal of virology.

[154]  J. Sierra,et al.  Prospective study of the incidence, clinical features, and outcome of symptomatic upper and lower respiratory tract infections by respiratory viruses in adult recipients of hematopoietic stem cell transplants for hematologic malignancies. , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[155]  T. Yoshikawa,et al.  A PROSPECTIVE STUDY OF HUMAN HERPESVIRUS‐6 INFECTION IN RENAL TRANSPLANTATION , 1992, Transplantation.

[156]  G. Palù,et al.  Investigation of intrarenal viral infections in kidney transplant recipients unveils an association between parvovirus B19 and chronic allograft injury. , 2009, The Journal of infectious diseases.

[157]  H. Einsele,et al.  Rapid generation of combined CMV-specific CD4+ and CD8+ T-cell lines for adoptive transfer into recipients of allogeneic stem cell transplants. , 2004, Blood.

[158]  M. Horowitz,et al.  Increasing incidence of adenovirus disease in bone marrow transplant recipients. , 1994, The Journal of infectious diseases.

[159]  P. Moss,et al.  Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines , 2003, The Lancet.

[160]  T. McLoud,et al.  CT manifestations of respiratory syncytial virus infection in lung transplant recipients. , 2000, Journal of computer assisted tomography.

[161]  T. Lion,et al.  Safe adoptive transfer of virus‐specific T‐cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation , 2006, British journal of haematology.

[162]  I. Ernberg,et al.  Epstein-Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease: prophylactic infusion of EBV-specific cytotoxic T cells. , 2000, Blood.

[163]  R. Margreiter,et al.  Rotavirus enteritis in solid organ transplant recipients: an underestimated problem? , 2007, Transplant infectious disease : an official journal of the Transplantation Society.

[164]  S. Mackinnon,et al.  Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease. , 1995, Blood.

[165]  J. Romagnoli,et al.  Large‐scale expansion of cytomegalovirus‐specific cytotoxic T cells in suspension culture , 2004, Biotechnology and bioengineering.

[166]  V. Reddy,et al.  Safety of allogeneic Epstein–Barr virus (EBV)‐specific cytotoxic T lymphocytes for patients with refractory EBV‐related lymphoma , 2002, British journal of haematology.

[167]  C. Rooney,et al.  Fiber-modified adenoviruses generate subgroup cross-reactive, adenovirus-specific cytotoxic T lymphocytes for therapeutic applications. , 2004, Blood.

[168]  S. Riddell,et al.  Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. , 1995, The New England journal of medicine.

[169]  A. Hansen,et al.  Prophylactic infusion of cytomegalovirus-specific cytotoxic T lymphocytes stimulated with Ad5f35pp65 gene-modified dendritic cells after allogeneic hemopoietic stem cell transplantation. , 2008, Blood.

[170]  M. Boeckh,et al.  Respiratory virus infection among hematopoietic cell transplant recipients: evidence for asymptomatic parainfluenza virus infection. , 2007, Blood.

[171]  M. Boeckh,et al.  Brief Communication: Fatal Human Metapneumovirus Infection in Stem-Cell Transplant Recipients , 2006, Annals of Internal Medicine.

[172]  S. Rowland-Jones,et al.  A re-evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers. , 1999, Journal of immunology.

[173]  D. van Baarle,et al.  Human herpes virus 6 plasma DNA positivity after hematopoietic stem cell transplantation in children: an important risk factor for clinical outcome. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[174]  B. Osborne,et al.  An outbreak of respiratory syncytial virus in a bone marrow transplant center. , 1992, The Journal of infectious diseases.

[175]  T. Welte,et al.  Community-Acquired Respiratory Viral Infections in Lung Transplant Recipients: A Single Season Cohort Study , 2009, Transplantation.

[176]  D. Jeyaratnam,et al.  Measles‐Associated Encephalopathy in Children with Renal Transplants , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[177]  E. Papoutsakis,et al.  Culture of human T cells in stirred bioreactors for cellular immunotherapy applications: Shear, proliferation, and the IL‐2 receptor , 2000, Biotechnology and bioengineering.

[178]  E. Bouza,et al.  BK virus in liver transplant recipients: a prospective study. , 2009, Transplantation proceedings.

[179]  P. Grabarczyk,et al.  Pure red cell aplasia due to parvovirus B19 infection transmitted probably through hematopoietic stem cell transplantation , 2008, Transplant infectious disease : an official journal of the Transplantation Society.

[180]  Nina Khanna,et al.  Cytomegalovirus and polyomavirus BK posttransplant. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[181]  C. Bordignon,et al.  The potential immunogenicity of the TK suicide gene does not prevent full clinical benefit associated with the use of TK-transduced donor lymphocytes in HSCT for hematologic malignancies. , 2007, Blood.

[182]  R. V. Van BInnendijk,et al.  Mumps: Not an Innocent Bystander in Solid Organ Transplantation , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[183]  S. Aydoğdu,et al.  Effect of rotavirus on serum tacrolimus level in pediatric liver transplant recipients , 2008, Pediatrics international : official journal of the Japan Pediatric Society.

[184]  H. Keyvani,et al.  Postrenal Transplant Hemophagocytic Lymphohistiocytosis and Thrombotic Microangiopathy Associated with Parvovirus B19 Infection , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[185]  P. Hanley,et al.  Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation. , 2009, Blood.

[186]  R. Krance,et al.  Adoptive immunotherapy with allodepleted donor T-cells improves immune reconstitution after haploidentical stem cell transplantation. , 2006, Blood.

[187]  Robin Patel,et al.  Parvovirus B19 infection after transplantation: a review of 98 cases. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[188]  A. B. Kay,et al.  Lymphocytes , 1991 .

[189]  D. Srivastava,et al.  Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients. , 1998, Blood.

[190]  C. Rooney,et al.  Contact-activated Monocytes: Efficient Antigen Presenting Cells for the Stimulation of Antigen-specific T cells , 2007, Journal of immunotherapy.

[191]  C. Sample,et al.  An Epstein-Barr virus deletion mutant associated with fatal lymphoproliferative disease unresponsive to therapy with virus-specific CTLs. , 2001, Blood.

[192]  C. Bollard,et al.  Human metapneumovirus infection in a hematopoietic transplant recipient , 2007, Bone Marrow Transplantation.